Abigail Shrier’s latest piece in the Wall Street Journal begins:
Is it safe for adolescents to undergo gender “transition”? Is it wise for children to take hormones that block puberty? The American Academy of Pediatrics not only has answered these questions in the affirmative but is determined to stifle any debate. On Friday the AAP told an international consortium of more than 100 clinicians and researchers who doubt the reigning orthodoxy that they couldn’t set up an information booth at the association’s national conference. The cosmetics company L’Oreal and the National Peanut Board will be there, but not the Society for Evidence-Based Gender Medicine. Source: Abigail Shrier, WSJ Article.
Thereby documenting the politicization of an important Medical Association, the AAP. The Cancel Culture is real. Here’s a link to SEGM, a group barred from setting up a booth at the AAP’s national conference. And a quote from their “About Us” page:
We are an international group of over 100 clinicians and researchers concerned about the lack of quality evidence for the use of hormonal and surgical interventions as first-line treatment for young people with gender dysphoria. We represent expertise from a range of clinical disciplines. - source: Society for Evidence-Based Gender Medicine
You should check them out. Many, many medical professionals are horrified by the rush to Transition young people with gender-dysphoria.
I’m convinced a deep-seated cultural agenda to
radically restructure society is driving all of this.
And now, as Shrier reports, many medical practitioners in Europe are reconsidering what they have done. You can check out a portion of the WSJ article here. (But most of the article is behind the WSJ paywall.)
In the article Shrier documents the current shift in Europe away from the Affirmative Care Model. Europe began this process of pushing gender-dysphoric children and teens to Transition several years before we did in North America. Now the evidence is compelling them to rethink their care models for patients under 18.
So should we.
Here’s an important graph:
In the past year, major hospitals in Europe have ended or curtailed pediatric hormone treatments in response to their own internal reviews. In March, the U.K.’s National Institute for Health and Care Excellence concluded that the benefits of hormone treatments for pediatric gender-dysphoria patients were unclear. The Karolinska Hospital of Sweden, which is affiliated with the institute that awards the Nobel Prize in medicine, in May decided to end its use of puberty blockers and cross-sex hormones for treatment of gender dysphoria for all patients under 18, except in controlled research settings. Finland’s national gender program issued new guidelines after noticing that many of the kids it treated with hormone therapy failed to show improvements in mental health. Source: Abigail Shrier, WSJ Article. [emphasis mine]
Josh Hammer nails it in this tweet.
The last graph before the paywall kicks in deserves your careful attention too.
I blogged about a remorseful DeTranstioner in my last post. Her name is Cari. Listen carefully to what she has to say.
***
If you’ve just found my blog and are intrigued about this issue, and want to learn more, I highly recommend the book by Abigail Shrier.
Shrier is a graduate of Columbia College who went on to earn a bachelor of philosophy degree from the University of Oxford and a JD from Yale Law School. Her book Irreversible Damage: The Transgender Craze Seducing Our Daughters was named a “best book” by The Economist and The Times of London. [2020, 2021]